Profile
Manfred Gröppel is the founder of Immunic AG, where he currently holds the title of Chief Operating Officer since 2016.
He previously worked as Director of Business Development at 4SC AG and as Chief Operating and Financial Officer at Vital Therapies, Inc. Dr. Gröppel also served as Chief Operating Officer at Immunic, Inc. from 2016 to 2021.
He holds a doctorate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Manfred Gröppel active positions
| Companies | Position | Start |
|---|---|---|
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Founder | 2016-03-31 |
Former positions of Manfred Gröppel
| Companies | Position | End |
|---|---|---|
| IMMUNIC, INC. | Chief Operating Officer | 2021-07-31 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
| 4SC AG | Corporate Officer/Principal | - |
Training of Manfred Gröppel
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| 4SC AG | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Manfred Gröppel
